Intrawound Vancomycin and Povidone-Iodine Treatment to Reduce Infection Rates in Arthroplasty

Area of Science:

• Orthopedic Surgery
• Infectious Disease Prevention
• Clinical Research

Background:

• Surgical site infections (SSIs) are a significant complication following arthroplasty.
• Preventative measures are crucial to reduce patient harm and improve outcomes.
• Intrawound vancomycin and povidone-iodine irrigation is a potential prophylactic strategy.

Purpose of the Study:

• To evaluate the efficacy of the vancomycin povidone-iodine protocol (VPIP) in preventing SSIs after arthroplasty.
• To compare infection rates between patients who received VPIP and those who did not.

Main Methods:

• Prospective observational study of arthroplasty patients (total knee, total hip, hip hemiarthroplasty).
• Exclusion criteria: <18 years old, known vancomycin allergy.
• Two groups: Group 1 (no VPIP), Group 2 (VPIP). Follow-up: 6 weeks. Outcome: Wound healing assessed by ASEPSIS score and infection category.

Main Results:

• Overall infection rates were 5.8% in Group 1 and 0.8% in Group 2.
• VPIP group had an 11-fold lower risk of infection (adjusted odds ratio = 11.651, P < 0.05).
• Diabetes mellitus was a significant risk factor for infection (P < 0.05).

Conclusions:

• The vancomycin povidone-iodine protocol (VPIP) is an effective measure for preventing surgical site infections in arthroplasty.
• Further randomized controlled trials are recommended to confirm effectiveness and justify widespread use.